Meet our Team
Committed to providing high quality & compassionate cardiovascular care
Canadian Cardiac Care's team of highly trained cardiologists and medical technicians work together to manage the complete range of cardiovascular care, from targeted risk management, effective preventative measures and evidence-based treatment options.
Our cardiologists have extensive scientific and academic experience remaining actively involved in both teaching and research. This ensures our doctors can provide tailored testing and treatments blending contemporary knowledge of medicine and state-of-the technology.
If you’d like to learn more about Canadian Cardiac Care or our physicians please contact us
Our cardiologists have extensive scientific and academic experience remaining actively involved in both teaching and research. This ensures our doctors can provide tailored testing and treatments blending contemporary knowledge of medicine and state-of-the technology.
If you’d like to learn more about Canadian Cardiac Care or our physicians please contact us
Canadian Cardiac Care Cardiologists
Working together to provide comprehensive cardiac care.
Wadea Tarhuni, MD
FRCPC, CCDS, FASE, FAHA, FESC
Cardiologist
Wadea Tarhuni, MD
Dr. Wadea Tarhuni is the president and lead cardiologist at the Canadian Cardiac Care. He is a recognized leader in the field of cardiology both locally and internationally as reflected through his multiple certifications including: the Royal College of Physicians and Surgeons of Canada, the American College of Physicians, the American College of Cardiology, the American Society of Echocardiography and the American Heart Association.
Dr. Tarhuni continuously researches and adopts cutting-edge technologies to enhance patient care, compliance, overall experience and health outcomes. Two such technologies include, the Cardiophone: a real-time wireless ECG recording device and the HandiECG: a hand-held device that does not require leads.
Dr. Tarhuni continuously researches and adopts cutting-edge technologies to enhance patient care, compliance, overall experience and health outcomes. Two such technologies include, the Cardiophone: a real-time wireless ECG recording device and the HandiECG: a hand-held device that does not require leads.
Jeff Healey, MD
MSc, FRCPC, FHRS
Cardiologist & Electrophysiologist
Jeff Healey, MD
Dr. Jeff Healey is an internationally recognized cardiologist/electrophysiologist and a leader in advanced diagnostics for arrhythmias. He is a professor of medicine at McMaster University in Hamilton, Ontario, Canada.
Dr. Healy is the Director of the Division of Cardiology and Population Health Research Institute Chair in Cardiology. He is also the chair of the Canadian Stroke Prevention and Intervention Network (CSPIN) and was the past chair of the Canadian Atrial Fibrillation Guidelines committee. He is actively involved in research and clinical trials, having published over 280 manuscripts and abstracts. His work as the lead author of the ASSERT trial, published in the New England Journal of Medicine in 2012, demonstrated the increased stroke risk associated with sub-clinical atrial fibrillation detected by pacemakers. He also lead the RELY AF cohort study, a 15,000 patient worldwide registry, published in the Lancet in 2016, that examined the causes, treatment and outcomes in patients with atrial fibrillation.
Dr. Healy is the Director of the Division of Cardiology and Population Health Research Institute Chair in Cardiology. He is also the chair of the Canadian Stroke Prevention and Intervention Network (CSPIN) and was the past chair of the Canadian Atrial Fibrillation Guidelines committee. He is actively involved in research and clinical trials, having published over 280 manuscripts and abstracts. His work as the lead author of the ASSERT trial, published in the New England Journal of Medicine in 2012, demonstrated the increased stroke risk associated with sub-clinical atrial fibrillation detected by pacemakers. He also lead the RELY AF cohort study, a 15,000 patient worldwide registry, published in the Lancet in 2016, that examined the causes, treatment and outcomes in patients with atrial fibrillation.
